{"entity":{"type":"insider","cik":"0001509160","url":"/insider/0001509160","json_url":"/insider/0001509160.json","name":"Vivo Ventures Fund VII, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":16,"first":"2013-05-20","last":"2022-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Vivo Ventures Fund VII, L.P.","source":"filing","n_filings":16,"first_seen":"2013-05-20","last_seen":"2022-01-31"}],"transactions":[{"id":6789207,"accession":"0001213900-22-004647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-004647","line_url":"/filing/0001213900-22-004647#line-1","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":null,"owner_name":"Vivo Ventures Fund VII, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Fund, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Capital Fund IX, L.P.; Vivo Capital IX, LLC","owner_display_name":"Vivo Ventures Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":21600000.0,"total_display":"21,600,000.00","total_whole":"21,600,000","shares_owned_after":2735853.0,"shares_owned_after_display":"2,735,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-01-31","scope":"insider"},{"id":6470703,"accession":"0001615774-18-009063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-18-009063","line_url":"/filing/0001615774-18-009063","is_derivative":false,"issuer_cik":"0001387156","issuer_name":"AIRXPANDERS INC","issuer_ticker":"AXP","issuer_name_source":null,"issuer_url":"/issuer/0001387156","owner_cik":null,"owner_name":"Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20142123.0,"shares_display":"20,142,123","price_per_share":0.1672,"price_display":"0.17","price_state":"stated","total_value":3367762.9656,"total_display":"3,367,762.97","total_whole":"3,367,763","shares_owned_after":36195409.0,"shares_owned_after_display":"36,195,409","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-30","filed_date":"2018-08-31","scope":"insider","n_lines":2},{"id":5231041,"accession":"0001615774-17-005168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-17-005168","line_url":"/filing/0001615774-17-005168","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures Fund VII, L.P.","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1060000.0,"shares_display":"1,060,000","price_per_share":5.775,"price_display":"5.78","price_state":"stated","total_value":6121500.0,"total_display":"6,121,500.00","total_whole":"6,121,500","shares_owned_after":4144495.0,"shares_owned_after_display":"4,144,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider","n_lines":2},{"id":4264026,"accession":"0001615774-17-000876","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001615774-17-000876","line_url":"/filing/0001615774-17-000876","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":31.2,"price_display":"31.20","price_state":"stated","total_value":3900000.0,"total_display":"3,900,000.00","total_whole":"3,900,000","shares_owned_after":2797597.0,"shares_owned_after_display":"2,797,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-02","scope":"insider","n_lines":2},{"id":4264021,"accession":"0001615774-17-000876","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001615774-17-000876","line_url":"/filing/0001615774-17-000876","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":30.98,"price_display":"30.98","price_state":"stated","total_value":3098000.0,"total_display":"3,098,000.00","total_whole":"3,098,000","shares_owned_after":2919931.0,"shares_owned_after_display":"2,919,931","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-02","scope":"insider","n_lines":2},{"id":4264016,"accession":"0001615774-17-000876","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-17-000876","line_url":"/filing/0001615774-17-000876","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":30.5,"price_display":"30.50","price_state":"stated","total_value":6100000.0,"total_display":"6,100,000.00","total_whole":"6,100,000","shares_owned_after":3017798.0,"shares_owned_after_display":"3,017,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-02","scope":"insider","n_lines":2},{"id":2464021,"accession":"0001615774-16-008485","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001615774-16-008485","line_url":"/filing/0001615774-16-008485","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures Fund VII, L.P.; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450000.0,"shares_display":"450,000","price_per_share":22.72,"price_display":"22.72","price_state":"stated","total_value":10224000.0,"total_display":"10,224,000.00","total_whole":"10,224,000","shares_owned_after":3213532.0,"shares_owned_after_display":"3,213,532","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-18","scope":"insider","n_lines":2},{"id":2464009,"accession":"0001615774-16-008485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615774-16-008485","line_url":"/filing/0001615774-16-008485","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures Fund VII, L.P.; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":457828.0,"shares_display":"457,828","price_per_share":23.336382331355882,"price_display":"23.34","price_state":"stated","total_value":10684049.25,"total_display":"10,684,049.25","total_whole":"10,684,049","shares_owned_after":3653934.0,"shares_owned_after_display":"3,653,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-18","scope":"insider","n_lines":2},{"id":2679066,"accession":"0001225208-16-039231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-16-039231","line_url":"/filing/0001225208-16-039231","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111600.0,"shares_display":"111,600","price_per_share":4.2529,"price_display":"4.25","price_state":"stated","total_value":474623.64,"total_display":"474,623.64","total_whole":"474,624","shares_owned_after":5181885.0,"shares_owned_after_display":"5,181,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-08","filed_date":"2016-09-12","scope":"insider","n_lines":2},{"id":2259464,"accession":"0001225208-16-038071","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-16-038071","line_url":"/filing/0001225208-16-038071","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":null,"owner_name":"Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36894.0,"shares_display":"36,894","price_per_share":4.2072,"price_display":"4.21","price_state":"stated","total_value":155220.4368,"total_display":"155,220.44","total_whole":"155,220","shares_owned_after":5291104.0,"shares_owned_after_display":"5,291,104","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider","n_lines":2},{"id":2259456,"accession":"0001225208-16-038071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-16-038071","line_url":"/filing/0001225208-16-038071","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":null,"owner_name":"Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":4.274,"price_display":"4.27","price_state":"stated","total_value":213700.0,"total_display":"213,700.00","total_whole":"213,700","shares_owned_after":5327211.0,"shares_owned_after_display":"5,327,211","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider","n_lines":2},{"id":3301310,"accession":"0001225208-16-037558","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-16-037558","line_url":"/filing/0001225208-16-037558","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures Fund VII, L.P.","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":4.1684,"price_display":"4.17","price_state":"stated","total_value":208420.0,"total_display":"208,420.00","total_whole":"208,420","shares_owned_after":5376145.0,"shares_owned_after_display":"5,376,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-04","filed_date":"2016-08-05","scope":"insider","n_lines":2},{"id":3301300,"accession":"0001225208-16-037558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-16-037558","line_url":"/filing/0001225208-16-037558","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures Fund VII, L.P.","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":4.2983,"price_display":"4.30","price_state":"stated","total_value":128949.0,"total_display":"128,949.00","total_whole":"128,949","shares_owned_after":5425079.0,"shares_owned_after_display":"5,425,079","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-03","filed_date":"2016-08-05","scope":"insider","n_lines":2},{"id":8676545,"accession":"0001209191-15-075198","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-075198","line_url":"/filing/0001209191-15-075198","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":454545.0,"shares_display":"454,545","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":4101997.0,"shares_owned_after_display":"4,101,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-13","filed_date":"2015-10-13","scope":"insider","n_lines":2},{"id":8676507,"accession":"0001209191-15-075023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-075023","line_url":"/filing/0001209191-15-075023","is_derivative":false,"issuer_cik":"0001509160","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001509160","owner_cik":null,"owner_name":"Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13352.0,"shares_display":"13,352","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":146872.0,"total_display":"146,872.00","total_whole":"146,872","shares_owned_after":296739.0,"shares_owned_after_display":"296,739","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-07","filed_date":"2015-10-09","scope":"insider","n_lines":2},{"id":8225514,"accession":"0001209191-15-061940","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-061940","line_url":"/filing/0001209191-15-061940","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"ProNAi Therapeutics Inc","issuer_ticker":"DNAI","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":220000.0,"shares_display":"220,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3740000.0,"total_display":"3,740,000.00","total_whole":"3,740,000","shares_owned_after":2433577.0,"shares_owned_after_display":"2,433,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-21","filed_date":"2015-07-21","scope":"insider","n_lines":2},{"id":5435139,"accession":"0000904454-13-001121","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-13-001121","line_url":"/filing/0000904454-13-001121#line-3","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":756.0,"shares_display":"756","price_per_share":8.27,"price_display":"8.27","price_state":"stated","total_value":6252.12,"total_display":"6,252.12","total_whole":"6,252","shares_owned_after":3098503.0,"shares_owned_after_display":"3,098,503","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-29","scope":"insider"},{"id":5435137,"accession":"0000904454-13-001121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-001121","line_url":"/filing/0000904454-13-001121#line-2","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38953.0,"shares_display":"38,953","price_per_share":8.3032,"price_display":"8.30","price_state":"stated","total_value":323434.5496,"total_display":"323,434.55","total_whole":"323,435","shares_owned_after":3099259.0,"shares_owned_after_display":"3,099,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-28","filed_date":"2013-10-29","scope":"insider"},{"id":5435134,"accession":"0000904454-13-001121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-001121","line_url":"/filing/0000904454-13-001121#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":259900.0,"shares_display":"259,900","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":2131180.0,"total_display":"2,131,180.00","total_whole":"2,131,180","shares_owned_after":3138212.0,"shares_owned_after_display":"3,138,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-25","filed_date":"2013-10-29","scope":"insider"},{"id":5521390,"accession":"0000904454-13-001090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-001090","line_url":"/filing/0000904454-13-001090#line-2","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":486107.0,"shares_display":"486,107","price_per_share":10.0009,"price_display":"10.00","price_state":"stated","total_value":4861507.4963,"total_display":"4,861,507.50","total_whole":"4,861,507","shares_owned_after":3398112.0,"shares_owned_after_display":"3,398,112","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-02","filed_date":"2013-10-03","scope":"insider"},{"id":5521389,"accession":"0000904454-13-001090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-001090","line_url":"/filing/0000904454-13-001090#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95539.0,"shares_display":"95,539","price_per_share":10.9973,"price_display":"11.00","price_state":"stated","total_value":1050671.0447,"total_display":"1,050,671.04","total_whole":"1,050,671","shares_owned_after":3884219.0,"shares_owned_after_display":"3,884,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider"},{"id":5313896,"accession":"0000904454-13-000776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000776","line_url":"/filing/0000904454-13-000776#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"Vivo Ventures Fund VII, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.","owner_display_name":"Vivo Ventures Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7337.0,"shares_display":"7,337","price_per_share":7.5777,"price_display":"7.58","price_state":"stated","total_value":55597.5849,"total_display":"55,597.58","total_whole":"55,598","shares_owned_after":3979758.0,"shares_owned_after_display":"3,979,758","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-28","filed_date":"2013-07-02","scope":"insider"},{"id":4902355,"accession":"0000904454-13-000695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000695","line_url":"/filing/0000904454-13-000695#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"VIVO VENTURES VII, LLC; Vivo Ventures VII Affiliates Fund, L.P.; Vivo Ventures Fund VII, L.P.","owner_display_name":"VIVO VENTURES VII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236273.0,"shares_display":"236,273","price_per_share":7.8,"price_display":"7.80","price_state":"stated","total_value":1842929.4,"total_display":"1,842,929.40","total_whole":"1,842,929","shares_owned_after":3987095.0,"shares_owned_after_display":"3,987,095","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-11","filed_date":"2013-06-13","scope":"insider"},{"id":4902349,"accession":"0000904454-13-000586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000586","line_url":"/filing/0000904454-13-000586#line-1","is_derivative":false,"issuer_cik":"0001262104","issuer_name":"MEI Pharma, Inc.","issuer_ticker":"MEIP","issuer_name_source":null,"issuer_url":"/issuer/0001262104","owner_cik":null,"owner_name":"Vivo Ventures VII Affiliates Fund, L.P.; VIVO VENTURES VII, LLC; Vivo Ventures Fund VII, L.P.","owner_display_name":"Vivo Ventures VII Affiliates Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17428.0,"shares_display":"17,428","price_per_share":9.0655,"price_display":"9.07","price_state":"stated","total_value":157993.534,"total_display":"157,993.53","total_whole":"157,994","shares_owned_after":4223368.0,"shares_owned_after_display":"4,223,368","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-16","filed_date":"2013-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2015-07-21","last_seen":"2022-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001387156","name":"AIRXPANDERS INC","url":"/issuer/0001387156","role":"Ten percent owner","n_filings":1,"first_seen":"2018-08-31","last_seen":"2018-08-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001200375","name":"CODEXIS INC","url":"/issuer/0001200375","role":"Ten percent owner","n_filings":4,"first_seen":"2016-08-05","last_seen":"2017-09-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Ten percent owner","n_filings":4,"first_seen":"2015-10-09","last_seen":"2017-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001262104","name":"MEI Pharma, Inc.","url":"/issuer/0001262104","role":"Ten percent owner","n_filings":5,"first_seen":"2013-05-20","last_seen":"2013-10-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001509160","retrieved_at":"2026-08-25T14:03:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}